SELLAS Life Sciences Group, Inc. Intellectual Property Contracts & Agreements

46 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
License Agreement between SELLAS Life Sciences Group, Inc. and GenFleet Therapeutics (Shanghai) Inc.
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
NY
2022
Exclusive License Agreement between SELLAS Life Sciences Group, SLSG Limited, LLC, and 3D Medicines Inc. (December 7, 2020)
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
NY
2021
First Amendment to Amended and Restated Exclusive License Agreement between SLSG Limited LLC and Memorial Sloan Kettering Cancer Center
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
NY
2020
License Agreement Between 38th Street Suites LLC and Sellas Life Sciences Group Inc. for Office Use at 15 West 38th Street, New York
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
NY
2018
Amendment to Exclusive License Agreement between Mills Pharmaceuticals, LLC and BioVascular, Inc.
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
2017
License and Supply Transfer Agreement between MonoSol Rx, LLC and Galena Biopharma, Inc.
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
2016
License and Supply Agreement between MonoSol Rx, LLC and Galena Biopharma, Inc. (July 17, 2014)
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
DE
2014
Exclusive License Agreement between Mills Pharmaceuticals, LLC and BioVascular, Inc. (December 20, 2013)
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
NY
2014
License and Development Agreement between Galena Biopharma, Apthera, and Dr. Reddy’s Laboratories (January 13, 2014)
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
DE
2014
License Agreement between Orexo AB and Galena Biopharma, Inc. dated March 15, 2013
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
CA
2013
Amendment No. 1 to License Agreement among Apthera, Inc., Kwangdong Pharmaceutical Co., Ltd., and Galena Biopharma, Inc.
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
2012
License Agreement between Apthera, Inc. and Kwangdong Pharmaceutical Co., Ltd. (Effective April 30, 2009)
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
AZ
2012
Exclusive License Agreement among The Henry M. Jackson Foundation, The University of Texas System, UT M.D. Anderson Cancer Center, and RXi Pharmaceuticals Corporation
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
TX
2011
Exclusive License Agreement between The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. and RXi Pharmaceuticals Corporation
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
MD
2011
Amendment No. 5 to Patent and Technology License Agreement among The University of Texas System, The Henry M. Jackson Foundation, and Apthera, Inc.
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
2011
Amendment No. 4 to Exclusive Patent and Technology License Agreement among University of Texas System, Henry M. Jackson Foundation, and Apthera, Inc.
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
2011
Amendment No. 3 to Exclusive Patent and Technology License Agreement among The University of Texas System, The Henry M. Jackson Foundation, and Apthera, Inc.
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
2011
Amendment No. 2 to Exclusive Patent and Technology License Agreement among The University of Texas System, The Henry M. Jackson Foundation, and Apthera, Inc.
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
2011
Amendment No. 1 to Exclusive Patent and Technology License Agreement among The Board of Regents of The University of Texas System, The Henry M. Jackson Foundation for the...
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
2011
Patent and Technology License Agreement among The University of Texas System, The Henry M. Jackson Foundation, and Advanced Peptide Therapeutics, Inc.
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
2011
Patent License Agreement between RXi Pharmaceuticals Corporation and Invitrogen IP Holdings, Inc. dated November 1, 2007
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
CA
2008
Patent License Agreement between Imperial College Innovations Limited, Imperial College of Science, Technology & Medicine, and CytRx Corporation (May 19, 2004)
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
MA
2008
Co-Exclusive License Agreement between University of Massachusetts Medical School and CytRx Corporation (UMMS Disclosure No. 03-33)
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
MA
2008
Exclusive License Agreement between University of Massachusetts Medical School and CytRx Corporation
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
MA
2008
Exclusive License Agreement between University of Massachusetts Medical School and CytRx Corporation for RNAi Technology
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
MA
2008
Amended and Restated Exclusive License Agreement between University of Massachusetts and CytRx Corporation
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
MA
2008
Exclusive License Agreement between University of Massachusetts Medical School and CytRx Corporation
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
MA
2008
Non-Exclusive License Agreement between University of Massachusetts Medical School and CytRx Corporation (April 15, 2003)
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
MA
2008
Non-Exclusive License Agreement between University of Massachusetts and RXi Pharmaceuticals Corporation
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
MA
2008
Exclusive License Agreement between University of Massachusetts and RXi Pharmaceuticals Corporation (UMMC 03-75-01)
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
MA
2008
Exclusive License Agreement between University of Massachusetts and RXi Pharmaceuticals Corporation (UMMC 03-68-02)
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
MA
2008
Exclusive License Agreement between University of Massachusetts and RXi Pharmaceuticals Corporation (UMMC 06-21-01)
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
MA
2008
License Agreement between Cold Spring Harbor Laboratory and RXi Pharmaceuticals Corp. for RNAi Intellectual Property (March 15, 2007)
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
NY
2008
Patent License Agreement between Imperial College Innovations Limited, Imperial College of Science, Technology & Medicine, and CytRx Corporation dated May 19, 2004
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
MA
2007
Exclusive License Agreement between CytRx Corporation and University of Massachusetts Medical School (UMMC 03-33-06)
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
MA
2007
Exclusive License Agreement between CytRx Corporation and University of Massachusetts Medical School (ALS Gene Therapy)
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
MA
2007
Exclusive License Agreement between CytRx Corporation and University of Massachusetts Medical School (RNAi Targeting of Viruses)
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
MA
2007
Amended and Restated Exclusive License Agreement between CytRx Corporation and University of Massachusetts Medical School
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
MA
2007
Exclusive License Agreement between CytRx Corporation and University of Massachusetts Medical School (April 15, 2003)
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
MA
2007
Non-Exclusive License Agreement between CytRx Corporation and University of Massachusetts Medical School (April 15, 2003)
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
MA
2007